Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, et al
Early intervention programs and special schooling are the most effective for those with this neurodevelopmental disorder, and although outcomes of early intervention vary, all children benefit (7)
Some patients start noticing results within 23 months, with clinical studies showing an average of 14.9% body weight loss after 68 weeks
Tirzepatide (Mounjaro) is a dual-action drug that not only acts on the GLP1a receptor but also the glucose-dependent insulinotropic polypeptide (GIP) receptor, giving (potentially) more potent effects
This prevents coring (punching a rubber fragment into the solution)
10.1016/j.bbrc.2010.10.130 Biochem